Clinical Trials Directory

Trials / Terminated

TerminatedNCT03898843

Assisted Animal Therapy: ReAnimal

Assisted Animal Therapy in a French Intensive Care Unit (ICU): An Open Randomized Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Assisted animal therapy (AAT) is getting more and more used worldwide, in such areas as gerontology, psychiatry, or oncology. It is a complementary therapy, and benefits for patients are various, including decrease of anxiety. In ICU, some case reports exist, but no study has ever been made in order to prove its benefits, not even its feasibility. In ReAnimal, the investigator aims to compare a group of patients receiving assisted animal therapy, versus a group of patients not receiving it. Primary objective will be the evolution of anxiety scores between the 2 groups of patients. Secondary objectives will be the comparison of mood scores, post traumatic stress syndrome scores, pain scores, and physiologic parameters such as blood pressure, cardiac frequency. The investigating team will also compare multi drug resistant bacteria incidence between the 2 groups. In the assisted animal therapy group, patients will also be asked to answer a satisfaction questionnaire.

Conditions

Interventions

TypeNameDescription
OTHERAnimal assisted therapyPatients of AAT group will leave their hospital bedroom to go in the session room, where they will meet a dog, who has come with his veterinary student master. Animal assisted therapy session will last at most 20 minutes, in which the patient is going to interact with the dog, pet him, play with him, etc.
BIOLOGICALNasal swab samplingAll patients will have nasal swab sampling at inclusion and 7 days after AAT session or sham session in order to screen multidrug resistant bacteria
BEHAVIORALSTAI-Y and POMS QuestionnairesBefore and after AAT or sham session, patients will answer State-Trait Anxiety Inventory Y (STAI-Y), Profile of Mood States (POMS) questionnaires.
PROCEDUREphysiological parameters measureBefore and after AAT or sham session, blood pressure, heart rate dans respiratory rate will be measured.
OTHERVisual Analog Scale (VAS)Before and after AAT or sham session, pain will be evaluated thanks to VAS
BEHAVIORALImpact of Event Scale - Revised (IES-R)Patients will answer IES-R questionnaire 3 months after AAT or sham session
BEHAVIORALsatisfaction questionnairePatients of the AAT group will answer satisfaction questionnaire at the end of the AAT session and 3 months after AAT
BIOLOGICALRectal swab samplingAll patients will have rectal swab sampling at inclusion and 7 days after AAT session or sham session in order to screen multidrug resistant bacteria

Timeline

Start date
2020-09-18
Primary completion
2022-08-24
Completion
2022-08-24
First posted
2019-04-02
Last updated
2023-05-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03898843. Inclusion in this directory is not an endorsement.